Coherus Rolls Out YUSIMRY At $995 Per Carton In US

RTTNews | 787日前
Coherus Rolls Out YUSIMRY At $995 Per Carton In US

(RTTNews) - Coherus BioSciences, Inc. (CHRS) announced Monday that YUSIMRY (adalimumab-aqvh) is now available for commercial sale in the United States at a list price of $995 per carton for two 40 mg/0.8 mL autoinjectors.

The pricing represents a discount of more than 85% to Humira (adalimumab), currently priced at $6,922 per carton of two pens.

YUSIMRY is presented in a state-of-the-art autoinjector and includes Coherus' proprietary non-stinging, citrate-free formulation and a 29-gauge needle.

YUSIMRY, approved in 2021 by the U.S. Food and Drug Administration, is a tumor necrosis factor blocker indicated to reduce the signs and symptoms of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and ankylosing spondylitis, and to treat Crohn's disease, ulcerative colitis, plaque psoriasis and hidradenitis suppurativa.

YUSIMRY Solutions - Coherus' patient services platform - will ensure improved access and a fast and seamless experience as patients start or switch to YUSIMRY treatment based on a determination by their healthcare provider.

read more
Coherus, Junshi Biosciences Say FDA Accepts Resubmission Of Toripalimab BLA

Coherus, Junshi Biosciences Say FDA Accepts Resubmission Of Toripalimab BLA

Coherus BioSciences, Inc. (CHRS) and Shanghai Junshi Biosciences Co., Ltd. announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) resubmission for toripalimab in combination with gemcitabine and cisplatin as first-line treatment for patients with advanced recurrent or metastatic nasopharyngeal carcinoma (NPC) and for toripalimab monotherapy for the second-line or later treatment of recurrent or metastatic NPC after platinum-containing chemotherapy.
RTTNews | 1149日前
Australian Market Swings To Modest Gains In Mid-market

Australian Market Swings To Modest Gains In Mid-market

The Australian stock market is swinging to modest gains in mid-market moves on Friday after opening in the red, extending the gains in the previous two sessions, following the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 9,000 mark, with gains in energy and technology stocks partially offset by weakness in mining and financial stocks.
RTTNews | 11分前
Asian Markets Mixed Amid Caution Trades

Asian Markets Mixed Amid Caution Trades

Asian stock markets are mixed on Friday, following the broadly positive cues from Wall Street overnight, ahead of the release of key U.S. inflation data later in the day that could impact the outlook for interest rates. Traders also digested highly anticipated earnings news from Nvidia, with the AI darling and market leader reporting second-quarter results that largely exceeded expectations.
RTTNews | 40分前
Thai Stock Market Tipped To Open In The Green

Thai Stock Market Tipped To Open In The Green

The Thai stock market on Thursday ended the two-day slide in which it had slipped almost 15 points or 1.2 percent. The Stock Exchange of Thailand now sits just above the 1,250-point plateau and it may open to the upside again on Friday.
RTTNews | 1時46分前
Japanese Market Notably Lower

Japanese Market Notably Lower

Giving up some of the gains in the previous two sessions, the Japanese market is notably lower on Friday, despite the broadly positive cues from Wall Street overnight. The Nikkei 225 is falling well below the 42,700 level, with weakness across most sectors led by exporters and technology stocks.
RTTNews | 2時3分前
Additional Support Predicted For Indonesia Shares

Additional Support Predicted For Indonesia Shares

The Indonesia stock market has moved higher in two consecutive trading days, gathering almost 50 points or 0.6 percent in that span. The Jakarta Composite Index now sits just above the 7,950-point plateau and it may add to its winnings on Friday.
RTTNews | 2時16分前
Australian Market Slightly Lower

Australian Market Slightly Lower

The Australian stock market is trading slightly lower on Friday, giving up some of the gains in the previous two sessions, despite the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 9,000 mark, with weakness in mining and financial stocks partially offset by gains in energy and technology stocks.
RTTNews | 2時25分前